Results
|
|
781.
|
|
|
|
782.
|
|
|
|
783.
|
|
|
|
784.
|
|
|
|
785.
|
|
|
|
786.
|
|
|
|
787.
|
|
|
|
788.
|
Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology. [electronic resource] by
- Kaplan, Muhammet Ali
- Isikdogan, Abdurrahman
- Koca, Doğan
- Kucukoner, Mehmet
- Gumusay, Ozge
- Yildiz, Ramazan
- Dayan, Adem
- Demir, Lütfiye
- Geredeli, Caglayan
- Kocer, Murat
- Arslan, Ulku Yalcintas
- Inal, Ali
- Akman, Tulay
- Coskun, Ugur
- Sener, Nur
- Inanc, Mevlude
- Elkiran, Emin Tamer
- Ozdemir, Nuriye Yildirim
- Durnalı, Ayse Gok
- Suner, Ali
- Alici, Suleyman
- Tarhan, Mustafa Oktay
- Boruban, Cem
- Oksuzoglu, Berna
- Urakci, Zuhat
Producer: 20150702
In:
Breast cancer (Tokyo, Japan) vol. 21
Availability: No items available.
|
|
|
789.
|
|
|
|
790.
|
Lapatinib activity in premalignant lesions and HER-2-positive cancer of the breast in a randomized, placebo-controlled presurgical trial. [electronic resource] by
- Decensi, Andrea
- Puntoni, Matteo
- Pruneri, Giancarlo
- Guerrieri-Gonzaga, Aliana
- Lazzeroni, Matteo
- Serrano, Davide
- Macis, Debora
- Johansson, Harriet
- Pala, Oriana
- Luini, Alberto
- Veronesi, Paolo
- Galimberti, Viviana
- Dotti, Maria Cristina
- Viale, Giuseppe
- Bonanni, Bernardo
Producer: 20120105
In:
Cancer prevention research (Philadelphia, Pa.) vol. 4
Availability: No items available.
|
|
|
791.
|
|
|
|
792.
|
Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers. [electronic resource] by
- Ding, Yi
- Gong, Chang
- Huang, De
- Chen, Rui
- Sui, Pinpin
- Lin, Kevin H
- Liang, Gehao
- Yuan, Lifeng
- Xiang, Handan
- Chen, Junying
- Yin, Tao
- Alexander, Peter B
- Wang, Qian-Fei
- Song, Er-Wei
- Li, Qi-Jing
- Wood, Kris C
- Wang, Xiao-Fan
Producer: 20181231
In:
Nature communications vol. 9
Availability: No items available.
|
|
|
793.
|
|
|
|
794.
|
A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells. [electronic resource] by
- Wood, Edgar R
- Truesdale, Anne T
- McDonald, Octerloney B
- Yuan, Derek
- Hassell, Anne
- Dickerson, Scott H
- Ellis, Byron
- Pennisi, Christopher
- Horne, Earnest
- Lackey, Karen
- Alligood, Krystal J
- Rusnak, David W
- Gilmer, Tona M
- Shewchuk, Lisa
Producer: 20041104
In:
Cancer research vol. 64
Availability: No items available.
|
|
|
795.
|
|
|
|
796.
|
Chromosome 17 polysomy without human epidermal growth factor receptor 2 amplification does not predict response to lapatinib plus paclitaxel compared with paclitaxel in metastatic breast cancer. [electronic resource] by
- Downey, Leona
- Livingston, Robert B
- Koehler, Maria
- Arbushites, Michael
- Williams, Lisa
- Santiago, Angela
- Guzman, Roberta
- Villalobos, Ivonne
- Di Leo, Angelo
- Press, Michael F
Producer: 20100426
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 16
Availability: No items available.
|
|
|
797.
|
|
|
|
798.
|
|
|
|
799.
|
|
|
|
800.
|
Pooled analysis of diarrhea events in patients with cancer treated with lapatinib. [electronic resource] by
- Crown, John P
- Burris, Harold A
- Boyle, Fran
- Jones, Suzanne
- Koehler, Maria
- Newstat, Beth O
- Parikh, Roma
- Oliva, Cristina
- Preston, Alaknanda
- Byrne, Julie
- Chan, Steve
Producer: 20090204
In:
Breast cancer research and treatment vol. 112
Availability: No items available.
|